Sen. Kyrsten Sinema, the conservative Democrat from Arizona, has emerged as a chief roadblock to Democrats’ plan to allow Medicare to use its bulk purchasing power to negotiate significantly lower prescription drug prices. Her opposition, which comes on the heels of a pro-Sinema ad blitz funded by drugmakers, could derail a plan that could save the government billions and cut the cost of many drugs by more than half.
As it turns out, not too long ago, Sinema promised Arizona voters something very different about drug prices.
ADDITIONALLY FOR PAID SUBSCRIBERS (click here to subscribe):
- Cutting drug profits won’t tank innovation.
- A Daily Poster subscriber spots more Big Pharma ads boosting its Democratic shills.
- Dozens of judges get caught playing dirty.
- A climate plan comes under fire.
- Instacart workers need your help.
If you’d like to read the full report, please click here to become an $8-a-month or $70-a-year supporting subscriber. When you become a supporting subscriber, you get this kind of exclusive content, you get access to our live events, you get our new Citizens' Guide To Holding The Powerful Accountable – and you are helping us hire more journalists.
Only paid subscribers can comment. Please subscribe or sign in to join the conversation.